Bristol Myers beats quarterly profit estimates on blood thinner, cancer drug sales

Investing.com Gold reports: Bristol Myers beats quarterly profit estimates on blood thinner, cancer drug sales. Full body text was unavailable at ingest time, so this brief is based on headline context.